Annual CFF
$17.34 M
+$17.34 M+376950.00%
31 December 2023
Summary:
Annovis Bio annual cash flow from financing activities is currently $17.34 million, with the most recent change of +$17.34 million (+376950.00%) on 31 December 2023. During the last 3 years, it has risen by +$5.30 million (+44.01%). ANVS annual CFF is now -62.89% below its all-time high of $46.74 million, reached on 31 December 2021.ANVS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$11.84 M
+$7.60 M+179.51%
30 September 2024
Summary:
Annovis Bio quarterly cash flow from financing activities is currently $11.84 million, with the most recent change of +$7.60 million (+179.51%) on 30 September 2024. Over the past year, it has increased by +$11.84 million (+100.00%). ANVS quarterly CFF is now -74.68% below its all-time high of $46.77 million, reached on 30 June 2021.ANVS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$29.26 M
+$11.84 M+67.99%
30 September 2024
Summary:
Annovis Bio TTM cash flow from financing activities is currently $29.26 million, with the most recent change of +$11.84 million (+67.99%) on 30 September 2024. Over the past year, it has increased by +$20.68 million (+240.99%). ANVS TTM CFF is now -37.45% below its all-time high of $46.77 million, reached on 30 June 2021.ANVS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANVS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +100.0% | +241.0% |
| 3 y3 years | +44.0% | +10000.0% | -37.4% |
| 5 y5 years | +6939.1% | +10000.0% | +6474.4% |
ANVS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -62.9% | >+9999.0% | at high | >+9999.0% | -37.4% | >+9999.0% |
| 5 y | 5 years | -62.9% | >+9999.0% | -74.7% | >+9999.0% | -37.5% | >+9999.0% |
| alltime | all time | -62.9% | >+9999.0% | -74.7% | >+9999.0% | -37.5% | >+9999.0% |
Annovis Bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.84 M(+179.5%) | $29.26 M(+68.0%) |
| June 2024 | - | $4.24 M(-4.1%) | $17.42 M(-19.9%) |
| Mar 2024 | - | $4.42 M(-49.6%) | $21.75 M(+25.4%) |
| Dec 2023 | $17.34 M(>+9900.0%) | $8.76 M(>+9900.0%) | $17.34 M(+102.2%) |
| Sept 2023 | - | $0.00(-100.0%) | $8.58 M(0.0%) |
| June 2023 | - | $8.57 M(>+9900.0%) | $8.58 M(>+9900.0%) |
| Mar 2023 | - | $7400.00(>+9900.0%) | $7400.00(+60.9%) |
| Dec 2022 | $4600.00(-100.0%) | $0.00(0.0%) | $4600.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $4600.00(-122.0%) |
| June 2022 | - | $0.00(-100.0%) | -$20.90 K(-100.0%) |
| Mar 2022 | - | $4600.00(>+9900.0%) | $46.75 M(+0.0%) |
| Dec 2021 | $46.74 M | $0.00(-100.0%) | $46.74 M(0.0%) |
| Sept 2021 | - | -$25.50 K(-100.1%) | $46.74 M(-0.1%) |
| June 2021 | - | $46.77 M(>+9900.0%) | $46.77 M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $3000.00(>+9900.0%) | -$42.40 K(-100.4%) |
| Dec 2020 | $12.04 M(+2618.0%) | $0.00(0.0%) | $12.04 M(+0.0%) |
| Sept 2020 | - | $0.00(-100.0%) | $12.04 M(+0.0%) |
| June 2020 | - | -$45.40 K(-100.4%) | $12.04 M(+0.3%) |
| Mar 2020 | - | $12.09 M(<-9900.0%) | $12.00 M(+2608.7%) |
| Dec 2019 | $443.10 K(+79.8%) | -$1900.00(-47.2%) | $443.10 K(-0.4%) |
| Sept 2019 | - | -$3600.00(-95.6%) | $445.00 K(-0.8%) |
| June 2019 | - | -$81.40 K(-115.4%) | $448.60 K(-15.8%) |
| Mar 2019 | - | $530.00 K(>+9900.0%) | $532.80 K(+116.2%) |
| Dec 2018 | $246.40 K(-25.9%) | $0.00(0.0%) | $246.40 K(0.0%) |
| Sept 2018 | - | $0.00(-100.0%) | $246.40 K(0.0%) |
| June 2018 | - | $2800.00(-98.9%) | $246.40 K(+1.1%) |
| Mar 2018 | - | $243.60 K | $243.60 K |
| Dec 2017 | $332.50 K | - | - |
FAQ
- What is Annovis Bio annual cash flow from financing activities?
- What is the all time high annual CFF for Annovis Bio?
- What is Annovis Bio annual CFF year-on-year change?
- What is Annovis Bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Annovis Bio?
- What is Annovis Bio quarterly CFF year-on-year change?
- What is Annovis Bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for Annovis Bio?
- What is Annovis Bio TTM CFF year-on-year change?
What is Annovis Bio annual cash flow from financing activities?
The current annual CFF of ANVS is $17.34 M
What is the all time high annual CFF for Annovis Bio?
Annovis Bio all-time high annual cash flow from financing activities is $46.74 M
What is Annovis Bio annual CFF year-on-year change?
Over the past year, ANVS annual cash flow from financing activities has changed by +$17.34 M (+376950.00%)
What is Annovis Bio quarterly cash flow from financing activities?
The current quarterly CFF of ANVS is $11.84 M
What is the all time high quarterly CFF for Annovis Bio?
Annovis Bio all-time high quarterly cash flow from financing activities is $46.77 M
What is Annovis Bio quarterly CFF year-on-year change?
Over the past year, ANVS quarterly cash flow from financing activities has changed by +$11.84 M (+100.00%)
What is Annovis Bio TTM cash flow from financing activities?
The current TTM CFF of ANVS is $29.26 M
What is the all time high TTM CFF for Annovis Bio?
Annovis Bio all-time high TTM cash flow from financing activities is $46.77 M
What is Annovis Bio TTM CFF year-on-year change?
Over the past year, ANVS TTM cash flow from financing activities has changed by +$20.68 M (+240.99%)